Molbank (May 2024)

4-(Tris(4-methyl-1<i>H</i>-pyrazol-1-yl)methyl)aniline

  • Bradley B. Garrison,
  • Joseph E. Duhamel,
  • Nehemiah Antoine,
  • Steven J. K. Symes,
  • Kyle A. Grice,
  • Colin D. McMillen,
  • Jared A. Pienkos

DOI
https://doi.org/10.3390/M1823
Journal volume & issue
Vol. 2024, no. 2
p. M1823

Abstract

Read online

4-(tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline was prepared in a 63% yield utilizing a C–F activation strategy from a mixture of 4-(trifluoromethyl)aniline, 4-methylpyrazole, and KOH in dimethylsulfoxide (DMSO). The identity of the product was confirmed by nuclear magnetic resonance spectroscopy, infrared spectroscopy, mass spectrometry, and single-crystal analysis. An analysis of crystals grown from the layering method (CH2Cl2/acetone/pentane) indicated two distinct polymorphs of the title compound. Moreover, density functional theory calculations utilizing the MN15L density functional and the def2-TZVP basis set indicated that 4-(tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline forms with similar energetics to the previously reported unmethylated analog.

Keywords